Cite
HARVARD Citation
Petrylak, D. et al. (2019). Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer. Prostate. 79 (6), pp. 604-613. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Petrylak, D. et al. (2019). Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer. Prostate. 79 (6), pp. 604-613. [Online].